The growth of the global magnetic resonance imaging (MRI) robot-assisted surgeries market at a CAGR of 13.91% during the forecast period 2023 to 2030

Market Research Future (MRFR) has published a half cooked research report on the “global magnetic resonance imaging (MRI) robot-assisted surgeries market”that contains the information from 2023 to 2030.

Market Highlights

The global magnetic resonance imaging (MRI) robot-assisted surgeries market is accounted to register a CAGR of 13.91% during the forecast period and is estimated to reach USD 6.02 billion by 2030.

The imperative role of MRI robot-assisted surgery is to perform surgical interventions more accurately, in less time, and more efficiently and effectively. The robot-assisted intervention with intra-operative MRI guidance offers unique advantages over other imaging modalities. The advantages include increased intervention accuracy, reduced procedure time, reduced cognitive load for the surgeon, and improved interventional ergonomics.

The market has been driven by several factors, such as improved outcomes for cancer patients and the fact that MRI robot-assisted surgeries offer advantages over other imaging modalities. However, the lack of awareness associated with MRI robot-assisted surgeries restrains the market's growth. Nonetheless, increased public and private sector investment creates more lucrative growth opportunities for market development.

Key Players

MRFR recognizes the following companies as the key players in the global magnetic resonance imaging (MRI) robot-assisted surgeries market—AiM Medical Robotics (US), IMRIS (Canada), Monteris Medical (Canada), Machnet Medical Robotics B.V (Netherlands), neuro42, Inc. (US), ACCURAY INCORPORATED (US), and Stereotaxis Inc. (US).

Segment Analysis

The global magnetic resonance imaging (MRI) robot-assisted surgeries market has been segmented based on product, application, and end user.

On the basis of product, the market is segmented into sensors, actuators, and robots. The sensors segment held the largest market share in 2022.

Based on application, the global magnetic resonance imaging (MRI) robot-assisted surgeries market has been segmented into oncology surgery, neurological surgery, and cardiovascular surgery. The oncology surgery segment is further segmented into prostate biopsy & brachytherapy, brain biopsy & intervention, breast cancer diagnosis & intervention, and liver cancer diagnosis & intervention. The oncology surgery market held the largest market share and is projected to be the fastest growing segment.

On the basis of the end user, the market is segmented into hospitals, ambulatory surgical centers, and specialty clinics. The hospitals segment held the largest market share during the forecast period owing to the rising preference of minimally invasive surgery (MIS) and increasing prevalence of cancer.

Browse In-depth Market Details [Table of Content, List of Figures, List of Tables] of Magnetic Resonance Imaging (MRI) Robot-Assisted Surgeries Market Research Report

Regional Analysis

The global magnetic resonance imaging (MRI) robot-assisted surgeries market, based on region, has been divided into North America, Europe, Asia-Pacific, and Rest of the World. North America consists of US and Canada. The Europe magnetic resonance imaging (MRI) robot-assisted surgeries market comprises of Germany, France, the UK, Italy, Spain, and the rest of Europe. The magnetic resonance imaging (MRI) robot-assisted surgeries market in Asia-Pacific has been segmented into China, India, Japan, Australia, South Korea, and the rest of Asia-Pacific. The Rest of the World magnetic resonance imaging (MRI) robot-assisted surgeries market comprises of Middle East, Africa, and Latin America.

Factors such as , advancements in robot manufacturing, and the increase in the use of robotic applications in cancer patients are expected to augment the demand for magnetic resonance imaging (MRI) robots in North America.

Moreover, factors such as the greater precision and safer surgical procedures provided by medical robots are also gaining ground, possibly leading to the growth of the medical robotics industry across the European region.

Additionally, the rising geriatric population and the rise in demand for minimally invasive and non-invasive surgical procedures are the major factors driving market growth in the Asia-Pacific region.

Furthermore, the rest of the world included the Middle East, Africa, and Latin America. The region accounted for the lowest market share in the magnetic resonance imaging (MRI) market for robotic-assisted surgeries. This is due to the presence of poorer economies lack effective healthcare infrastructure, and lower healthcare spending.

Key Findings of the Study

• The global magnetic resonance imaging (MRI) robot-assisted surgeries market is expected to reach USD 6.02 billion by 2030, at a CAGR of 13.91% during the forecast period.


• The Asia-Pacific region accounted for the fastest-growing global market, owing to the increase in the adoption of MRI robots in hospitals as well as rising cancer incidences.


• Based on application, the oncology surgery segment was attributed to holding the largest market in 2022, with an approximate market share of 55–65%.


• AiM Medical Robotics (US), IMRIS (Canada), Monteris Medical (Canada), Machnet Medical Robotics B.V (Netherlands), neuro42, Inc. (US), ACCURAY INCORPORATED (US), and Stereotaxis Inc. (US) are the key market players.